SEI Trust Company’s Alexion Pharmaceuticals ALXN Stock Holding History

SEI Trust Company’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$33.2M	Buy	200,372 +30,546	+18%	+$5.02M	0.32%	72
2014 Q2	$26.5M	Sell	169,826 -15,746	-8%	-$2.49M	0.26%	93
2014 Q1	$28.2M	Sell	185,572 -36,673	-17%	-$5.83M	0.28%	79
2013 Q4	$29.6M	Buy	222,245 +29,192	+15%	+$3.5M	0.28%	78
2013 Q3	$22.4M	Sell	193,053 -118,281	-38%	-$13M	0.25%	100
2013 Q2	$28.7M	Buy	+311,334	New	+$30M	0.35%	73

Other funds holding ALXN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SEI Trust Company's ALXN Position: Q3 2014 in Review

SEI Trust Company increased its Alexion Pharmaceuticals (ALXN) stake by 18% in Q3 2014, buying an estimated $5.02M and bringing the position to 200,372 shares worth $33.2M. The position accounts for 0.32% of the portfolio, ranked #72.

SEI Trust Company first reported a position in ALXN in Q2 2013 and has held it in 6 quarters since. 522 funds tracked by Wall St. Rank hold ALXN as of Q3 2014.

SEI Trust Company held 200,372 shares of Alexion Pharmaceuticals worth $33.2M as of Q3 2014.
SEI Trust Company bought 30,546 Alexion Pharmaceuticals shares in Q3 2014, an estimated $5.02M.
Alexion Pharmaceuticals made up 0.32% of SEI Trust Company's portfolio in Q3 2014, its #72 holding.
SEI Trust Company first reported a position in Alexion Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
522 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2014.

Based on SEI Trust Company's 13F filing for Q3 2014, filed 28 Oct 2014.